HIT Consultant April 12, 2024
What You Should Know:
– Elucent Medical, a leader in surgical navigation with its In-Site Spatial Intelligence (iSI) technology raises $42.5M in Series C funding, led by Vensana Capital and RC Capital with participation from existing investors.
– This significant investment will fuel the development and commercialization of Elucent’s innovative EnVisio® and SmartClip® technologies, designed to improve precision and effectiveness in cancer surgery.
Pioneering In-Site Spatial Intelligence
Elucent’s flagship technologies, EnVisio® and SmartClip®, provide surgeons with real-time, in-situ (within the body) spatial intelligence during critical operations. EnVisio® utilizes proprietary technology to transform standard surgical instruments into “smart” tools. These smart tools can be tracked in real-time and guided with millimeter precision, enabling surgeons to operate with greater accuracy.
EnVisio®:...
Today's Sponsors
Today's Sponsor